Aspartate beta-hydroxylase promotes cholangiocarcinoma progression by modulating RB1 phosphorylation

about

Aspartate beta-hydroxylase promotes cholangiocarcinoma progression by modulating RB1 phosphorylation

Item

http://www.wikidata.org/entity/Q57112122

description

im August 2018 veröffentlichter wissenschaftlicher Artikel

@de

wetenschappelijk artikel

@nl

наукова стаття, опублікована в серпні 2018

@uk

name

Aspartate beta-hydroxylase pro ...... modulating RB1 phosphorylation

@en

Aspartate beta-hydroxylase pro ...... modulating RB1 phosphorylation

@nl

type

Item

label

Aspartate beta-hydroxylase pro ...... modulating RB1 phosphorylation

@en

Aspartate beta-hydroxylase pro ...... modulating RB1 phosphorylation

@nl

prefLabel

Aspartate beta-hydroxylase pro ...... modulating RB1 phosphorylation

@en

Aspartate beta-hydroxylase pro ...... modulating RB1 phosphorylation

@nl

P1476

Aspartate beta-hydroxylase pro ...... modulating RB1 phosphorylation

@en

P2093

Chengcheng Ji

http://www.w3.org/2001/XMLSchema#string

Jack R Wands

http://www.w3.org/2001/XMLSchema#string

Jin-Song Gao

http://www.w3.org/2001/XMLSchema#string

Jing Zou

http://www.w3.org/2001/XMLSchema#string

Katsuya Nagaoka

http://www.w3.org/2001/XMLSchema#string

Kevin Y Cao

http://www.w3.org/2001/XMLSchema#string

Kousuke Ogawa

http://www.w3.org/2001/XMLSchema#string

Rolf I Carlson

http://www.w3.org/2001/XMLSchema#string

Sarah Casulli

http://www.w3.org/2001/XMLSchema#string

Shaolei Lu

http://www.w3.org/2001/XMLSchema#string

P2860

Cancer-associated IDH1 mutations produce 2-hydroxyglutarate

Overexpression of human aspartyl(asparaginyl)beta-hydroxylase in hepatocellular carcinoma and cholangiocarcinoma

Mutations in isocitrate dehydrogenase 1 and 2 occur frequently in intrahepatic cholangiocarcinomas and share hypermethylation targets with glioblastomas

Oncometabolite 2-hydroxyglutarate is a competitive inhibitor of α-ketoglutarate-dependent dioxygenases

An integrated genomic analysis of human glioblastoma multiforme

IDH1 and IDH2 mutations in gliomas

Cholangiocarcinoma

Targeted inhibition of mutant IDH2 in leukemia cells induces cellular differentiation

An inhibitor of mutant IDH1 delays growth and promotes differentiation of glioma cells.

Overexpression of human aspartyl (asparaginyl) beta-hydroxylase is associated with malignant transformation

P304

1-10

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.CANLET.2018.04.041

http://www.w3.org/2001/XMLSchema#string

P407

English

P478

429

http://www.w3.org/2001/XMLSchema#string

P50

Chiung-Kuei Huang

P577

2018-08-10T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29733964

http://www.w3.org/2001/XMLSchema#string

P921

phosphorylation

cancer research

P932

5985220

http://www.w3.org/2001/XMLSchema#string